BioNTech Company

Biontech has been developing drugs against cancer, but a recent cash injection from Chinese drugmaker Fosun Pharma would allow it to speed up its efforts in the global race to find a vaccine against the novel pathogen, Biontech announced Monday (March 17). The Chinese offered €120 million ($133.3 million), some €44 million of the sum are in exchange for shares in Biontech.
Technology: COVID
Industry: Vaccine/Drug
Headquarters: Germany
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Register and Claim Ownership